Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2015, Article ID 793786, 4 pages
http://dx.doi.org/10.1155/2015/793786
Case Report

Severe Legionnaires’ Disease Complicated by Rhabdomyolysis and Clinically Resistant to Moxifloxacin in a Splenectomised Patient: Too Much of a Coincidence?

1Department of Internal Medicine, General Hospital of Larissa, 1 Tsakalof Street, 41221 Larissa, Greece
2Department of Microbiology, General Hospital of Larissa, 41221 Larissa, Greece

Received 23 October 2015; Accepted 10 November 2015

Academic Editor: Gernot Walder

Copyright © 2015 Theocharis Koufakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Campèse, G. Descours, A. Lepoutre et al., “Legionnaires’ disease in France,” Médecine et Maladies Infectieuses, vol. 45, no. 3, pp. 65–71, 2015. View at Publisher · View at Google Scholar
  2. I. A. Gonzalez and J. M. Martin, “Legionella pneumophilia serogroup 1 pneumonia recurrence postbone marrow transplantation,” Pediatric Infectious Disease Journal, vol. 26, no. 10, pp. 961–963, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. American Thoracic Society, “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  4. J. Povová, R. Zlámalová, A. Hozák et al., “Epidemiology and risk factors in legionellosis,” Epidemiologie, Mikrobiologie, Imunologie, vol. 63, no. 4, pp. 285–288, 2014. View at Google Scholar · View at Scopus
  5. J. Ambrose, L. M. Hampton, K. E. Fleming-Dutra et al., “Large outbreak of Legionnaires' disease and Pontiac fever at a military base,” Epidemiology and Infection, vol. 142, no. 11, pp. 2336–2346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Taha, T. M. Al-Ayed, S. A. Al-Haider, and H. H. Frayha, “Lethal Legionella infection in an immunocompromised child: first reported case in the Middle East,” Annals of Saudi Medicine, vol. 32, no. 4, pp. 430–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Singh and W. M. Scheld, “Infectious etiologies of rhabdomyolysis: three case reports and review,” Clinical Infectious Diseases, vol. 22, no. 4, pp. 642–649, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. L. S. Tkatch, S. Kusne, W. D. Irish, S. Krystofiak, and E. Wing, “Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center,” Clinical Infectious Diseases, vol. 27, no. 6, pp. 1479–1486, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. C. H. Heath, D. I. Grove, and D. F. M. Looke, “Delay in appropriate therapy of Legionella pneumonia associated with increased mortality,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 15, no. 4, pp. 286–290, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Kümpers, A. Tiede, P. Kirschner, J. Girke, A. Ganser, and D. Peest, “Legionnaires' disease in immunocompromised patients: a case report of Legionella longbeachae pneumonia and review of the literature,” Journal of Medical Microbiology, vol. 57, no. 3, pp. 384–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. La Scola and H. Maltezou, “Legionella and Q fever community acquired pneumonia in children,” Paediatric Respiratory Reviews, vol. 5, pp. S171–S177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Benin, R. F. Benson, and R. E. Besser, “Trends in Legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosis,” Clinical Infectious Diseases, vol. 35, no. 9, pp. 1039–1046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Rello, S. Gattarello, J. Souto et al., “Community-acquired Legionella pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy,” Medicina Intensiva, vol. 37, pp. 320–326, 2013. View at Google Scholar
  14. N. Phin, F. Parry-Ford, T. Harrison et al., “Epidemiology and clinical management of Legionnaires' disease,” The Lancet Infectious Diseases, vol. 14, no. 10, pp. 1011–1021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. R. Posner, M. A. Caudill, R. Brass, and E. Ellis, “Legionnaires' disease associated with rhabdomyolysis and myoglobinuria,” Archives of Internal Medicine, vol. 140, no. 6, pp. 848–850, 1980. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Schlossberg and J. Bonoan, “Legionella and immunosuppression,” Seminars in Respiratory Infections, vol. 13, no. 2, pp. 128–131, 1998. View at Google Scholar · View at Scopus
  17. C. Chidiac, D. Che, S. Pires-Cronenberger et al., “Factors associated with hospital mortality in community-acquired legionellosis in France,” European Respiratory Journal, vol. 39, no. 4, pp. 963–970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. A. Cunha and J. E. Hage, “Legionella pneumophila community-acquired pneumonia (CAP) in a post-splenectomy patient with myelodysplastic syndrome (MDS),” Heart and Lung, vol. 41, no. 5, pp. 525–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Gorelik, Z. Lazarovich, I. Boldur et al., “Legionella in two splenectomized patients. Coincidence or causal relationship?” Infection, vol. 32, no. 3, pp. 179–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Burdet, R. Lepeule, X. Duval et al., “Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 9, pp. 2354–2360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. T. Griffin, P. Peyrani, T. Wiemken, and F. Arnold, “Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 4, pp. 495–499, 2010. View at Google Scholar
  22. A. Mykietiuk, J. Carratalà, N. Fernández-Sabé et al., “Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy,” Clinical Infectious Diseases, vol. 40, no. 6, pp. 794–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Bruin, T. Koshkolda, E. P. IJzerman, C. Lück, B. M. Diederen, and J. W. Den Boer, “Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 10, pp. 2869–2871, 2014. View at Publisher · View at Google Scholar
  24. C. Onody, P. Matsiota-Bernard, and C. Nauciel, “Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila,” Journal of Antimicrobial Chemotherapy, vol. 39, no. 6, pp. 815–816, 1997. View at Publisher · View at Google Scholar · View at Scopus